A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Some Doubts on the Study of Clinical Prognoses of Patients with a Bloodstream Infection Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis
2019
Antimicrobial Agents and Chemotherapy
W e read with great interest the article in an issue of Antimicrobial Agents and Chemotherapy by Kim et al. (1). The article concluded that the mortality rates of patients stratified by penicillin susceptibility might be relevant to the treatment failures of ampicillin and/or piperacillin in patients with an ampicillin-susceptible but penicillinresistant (ASPR) Enterococcus faecalis bloodstream infection (BSI). Though an interesting and valuable study has been conducted, some methodological
doi:10.1128/aac.01596-19
fatcat:t7oiqegcvbg3vamojilzwfrj3y